• Toremifene: Precision Tool for Selective Estrogen-Receptor M

  2026-05-21

  Toremifene empowers researchers to dissect estrogen receptor signaling and calcium-driven metastatic pathways in hormone-responsive prostate cancer models. This guide delivers actionable workflows, troubleshooting insights, and translational strategies to leverage Toremifene’s potent, quantifiable activity in advanced experimental settings.

• TSPAN18 Protects STIM1 to Drive Bone Metastasis in Prostate

  2026-05-20

  Zhou et al. reveal that TSPAN18 promotes bone metastasis in prostate cancer by inhibiting TRIM32-mediated ubiquitination of STIM1, stabilizing STIM1 protein and activating calcium signaling. This mechanistic insight highlights TSPAN18 as a potential therapeutic target and provides new context for designing advanced hormone-responsive cancer research workflows.

• TPPU and Soluble Epoxide Hydrolase Inhibition: Redefining Li

  2026-05-20

  Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, advances research on lipid signaling, bone metabolism, and chronic inflammation. This article uniquely dissects new mechanistic insights and practical assay implications, setting it apart from prior reviews.

• SB 203580: Precision Targeting of p38 MAPK in Regenerative R

  2026-05-19

  Explore the multifaceted applications of SB203580, a selective p38 MAPK inhibitor, in regenerative medicine and advanced cell signaling studies. This article delivers a deep dive into its molecular action, translational relevance, and protocol nuances that distinguish its use in next-generation research.

• 12-O-tetradecanoyl phorbol-13-acetate (TPA): Precision Contr

  2026-05-19

  Explore how 12-O-tetradecanoyl phorbol-13-acetate (TPA) enables precise, tunable ERK/MAPK pathway activation for advanced disease modeling and signal transduction assay design. This article delivers a deeper mechanistic perspective, focusing on actionable insights for researchers.

• Distinct Apoptotic Pathways in BMECs Induced by C. krusei Ph

  2026-05-18

  This study demonstrates that Candida krusei induces apoptosis in bovine mammary epithelial cells (BMECs) via distinct mechanisms, with the yeast phase activating a mitochondrial pathway and the hypha phase triggering a death ligand/receptor pathway. The findings deepen our understanding of mycotic mastitis pathogenesis and point to specific MAPK signaling components as potential therapeutic targets.

• Universal Method for Dual-Loaded Liposome Encapsulation Effi

  2026-05-18

  This study introduces a robust nanoparticle exclusion chromatography (nPEC) method for accurately determining the encapsulation efficiency of dual-loaded liposomes containing both hydrophilic and lipophilic drugs. The findings advance drug delivery research by enabling precise, reproducible assessment across diverse compound pairs, supporting translational applications in combination therapy.

• PPM-18 for Precision NF-κB Inhibition in Sepsis Research

  2026-05-17

  PPM-18, a potent NF-κB pathway inhibitor, empowers researchers to achieve reproducible iNOS modulation in inflammation and sepsis models. Applied insights, protocol guidance, and troubleshooting tips maximize its impact for translational studies.

• Cannabidiol’s Role in Modulating Orofacial Inflammatory Pain

  2026-05-16

  This study demonstrates that cannabidiol (CBD) robustly attenuates both sensory and affective dimensions of orofacial inflammatory pain in mouse models, acting through peripheral and central endocannabinoid and serotonergic pathways. These findings highlight CBD’s translational potential for integrated management of pain and mood disturbances, and inform future investigations into endocannabinoid signaling modulation.

• Glabridin-Gold(I) Complex Enhances Antitumor Immunity via Tr

  2026-05-15

  This study introduces a glabridin-gold(I) complex (6d) as a novel immunomodulatory agent that synergistically targets thioredoxin reductase and MAPK pathways, enhancing antitumor immunity in liver cancer models. The dual-action mechanism not only boosts dendritic cell maturation and cytotoxic T cell activity but also reduces immunosuppressive cell populations, offering a promising strategy for combinatorial cancer immunotherapy.

• Protease Inhibitor Cocktail: Precision Protein Extraction Un

  2026-05-15

  Unlock uncompromised protein stability for Western blotting, Co-IP, and phosphorylation-sensitive assays with APExBIO’s EDTA-free Protease Inhibitor Cocktail. Its DMSO-based, 200X concentrated format enables broad-spectrum, cation-friendly protection, empowering reproducible results in both discovery and translational workflows.

• Anti-Fibrotic Actions of 1-Phenyl-2-Pentanol in Hepatic Stel

  2026-05-14

  This study identifies 1-phenyl-2-pentanol from Moringa oleifera as a potent regulator of hepatic stellate cell activation, targeting both TGF-β1 and Wnt/β-catenin pathways to suppress fibrogenic signaling. The findings highlight a dual-mechanism approach for anti-fibrotic intervention, providing new directions for liver fibrosis research.

• Difloxacin HCl: Optimizing Antimicrobial and MDR Assays

  2026-05-14

  Difloxacin HCl stands out as a high-purity quinolone antimicrobial antibiotic, enabling precise antimicrobial susceptibility testing and robust reversal of multidrug resistance in research settings. This article delivers actionable protocol enhancements, troubleshooting strategies, and cross-domain workflow insights for biomedical researchers seeking reproducible and efficient outcomes.

• Polyethylenimine Linear (PEI), MW 40,000: Reliable DNA Trans

  2026-05-13

  This article delivers a scenario-driven, evidence-based exploration of Polyethylenimine Linear (PEI), MW 40,000 (SKU K1029) for in vitro DNA transfection, transient gene expression, and recombinant protein production. Drawing on real laboratory challenges, protocol optimizations, and peer-reviewed literature, it demonstrates how SKU K1029 enables reproducible, high-efficiency transfection across diverse cell lines and scales.

• Polyethylenimine Linear (PEI MW 40,000): High-Efficiency DNA

  2026-05-13

  Polyethylenimine Linear (PEI MW 40,000) is a robust DNA transfection reagent for in vitro studies, delivering high efficiency across mammalian cell lines from 96-well plates to bioreactors. Its versatility, serum compatibility, and performance in transient gene expression and recombinant protein production set it apart for both routine and large-scale applications.

16549 records 2/1104 page Previous Next 12345 下5页 Last page